MSB 6.55% $1.47 mesoblast limited

ODAC August 2020 event materials, page-63

  1. 5,935 Posts.
    lightbulb Created with Sketch. 2128
    Yes, and FDA says the same results in another trial can lead to approval. Simply use pain as the primary end point. Imagine that. Pain as primary end point in a treatment to reduce.... what was it? Oh yeah, pain.

    Speaking of which, YT, sometimes you can be a real...
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.